Kintyre House
209 Govan Road
Glasgow G51 1HJ
United Kingdom
44 1413 700 321
https://rafina-innovations.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 4
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Nikolaos Kardaras | Head of Legal Department | N/D | N/D | 1950 |
Ms. Paraskevi Pilarinou | Financial Controller | 115,82k | N/D | N/D |
Ms. Paraskevi Pylarinou | CFO, Secretary & Director | N/D | N/D | 1988 |
Dr. Hari Elangovan | Acting Chief Technology Officer | N/D | N/D | N/D |
Ms. Evaggelia Moschidou | Marketing Director | N/D | N/D | N/D |
Mr. Georgios Thrapsaniotis | Treasurer & Director | N/D | N/D | 1945 |
Mr. Yiannis Levantis | Independent Technology Advisor & Director | N/D | N/D | 1976 |
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.
L'ISS Governance QualityScore di Rafina Innovations Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.